4//SEC Filing
Sherman Rachel E. 4
Accession 0001209191-23-027339
CIK 0001818331other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 4:15 PM ET
Size
11.6 KB
Accession
0001209191-23-027339
Insider Transaction Report
Form 4
Sherman Rachel E.
Director
Transactions
- Exercise/Conversion
Restricted Stock Unit
2023-05-02−45,454→ 0 total→ Class A Common Stock (45,454 underlying) - Exercise/Conversion
Class A Common Stock
2023-05-02+45,454→ 58,290 total
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
- [F2]The underlying shares shall vest on the earlier of the (a) date of the 2023 annual meeting of the Issuer's stockholders, and (b) first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer on the applicable vesting date.
Documents
Issuer
GeneDx Holdings Corp.
CIK 0001818331
Entity typeother
Related Parties
1- filerCIK 0001784705
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 4:15 PM ET
- Size
- 11.6 KB